
Appendicitis: What's Old, What's New?
This course is part of a series highlighting selected panel sessions from Clinical Congress 2024. In preparation for the webinar, all registered attendees, new and returning, are encouraged to review the recorded content from the original session in San Francisco. This will ensure a deeper understanding of the material and allow for a more engaging discussion during the webinar.
The treatment of appendicitis has changed dramatically over the past decade. Appendectomy, once done open, now done via minimally invasive techniques, has historically been the gold standard treatment of appendicitis. Non-surgical approach of acute appendicitis with antibiotics has recently become part of our treatment options. How are the clinical outcomes and results of antibiotics therapy holding up as observations now extend to more years than previously reported? Is there any reversion to appendectomy? What is the current best therapy for uncomplicated and complicated appendicitis? What does the future hold? This session will cover advances and changes in the modern management of appendicitis.
The live webinar will take place on Thursday, February 20, 2025, 6:00 - 7:00 pm CT.
Target Audience
- Practicing Surgeons
- Residents
- Medical Students
Learning Objectives
At the conclusion of the course, participants should be able to do the following:
• Learners will be able to outline the spectrum of appendicitis management from the open appendectomy era to modern strategies including robotic appendectomy and non-operative management with antibiotics.
• Learners will be able to explain the nuanced benefits and drawbacks of a robotic approach to appendectomy.
• Learners will be able to compare the outcome of antibiotic therapy for appendicitis to the outcomes of surgical management.
Contact
- If you have questions about the course, please contact [email protected].
- For technical questions, please contact [email protected].
Disclosure Information
In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.
Ineligible company
The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
Financial Relationships
Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
Planning Committee Disclosures
Fabrizio Michelassi, MD, FACS, MAMSE - Tsumura, Inc.
Sharmila Dissanaike, MD, FACS, FCCM - Heron Therapeutics
Brooke C. Bredbeck, MD - Nothing to disclose
Kellie R. Brown, MD, FACS - Nothing to disclose
Yolanda L. Colson, MD, PhD, FACS - Canon USA; Stryker
Cynthia D. Downard, MD, MMSc, FACS, FAAP - Nothing to disclose
Quan-Yang Duh, MD, FACS - Nothing to disclose
Neal D. Futran, MD, DMD, FACS - Stryker
B.J. Hancock, MD, FRCSC, FACS - Nothing to disclose
Jonathan A. Laryea, MBChB, FACS, FASCRS, FWACS - Nothing to disclose
Amy E. Liepert, MD, FACS - Nothing to disclose
Ronald V. Maier, MD, FACS, FRCSED(Hon), FCSHK(Hon), FCCS(Hon), FISS(Hon), MAMSE - Nothing to disclose
Viraj Master, MD, PhD, FACS - Ethicon; Exelixis
Nipun B. Merchant, MD, FACS - Nothing to disclose
Susan C. Modesitt, MD, FACOG, FACS - Nothing to disclose
Lena Napolitano, MD FACS, MAMSE - Nothing to disclose
M. Timothy Nelson, MD, FACS, DABS - Nothing to disclose
Patrick R. Reardon, MD, FACS - Nothing to disclose
Kenneth W. Sharp, MD, FACS, MAMSE - Nothing to disclose
Ali Tavakkoli, MBBS, FACS - AltrixBio
Steve D. Wexner, MD, PhD (Hon), FACS, FRCS (Eng), FRCS(Ed), FRCSI (Hon), Hon FRCS (Glasg), Hon FRCS (Eng), MAMSE - Baxter; BD (Becton, Dickinson & Co); Glaxo Smith Kline; Intuitive Surgical; Livsmed; Medtronic; OstomyCure; Stryker; Takeda; Virtual Ports; JSR/WCG/ACI; Polypid; Boomerang; Intuitive Surgical; Karl Storz Endoscopy America Inc; Unique Surgical Innovations LLC; Pragma/GibLib; Renew Medical
Speakers/Faculty Disclosures
Jill R. Streams, MD, FACS – Prytime Medical
Stephanie Streit, MD, FACS – Nothing to disclose
Robert J. Winchell, MD, FACS – Intuitive Corporation
Patricia Ayoung-Chee, MD, FACS – Nothing to disclose
Continuing Medical Education Credit Information
Accreditation
The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credits™
The American College of Surgeons designates this Hybrid/Other activity for a maximum of 2.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program.
Credit Claiming Information
Please complete the overall course evaluation to claim a CME Certificate or a Certificate of Completion. The course evaluation will appear once you take and complete this course. The following requirements need to be completed:
- Review all course materials
- Course evaluation
This course is available for claiming partial credit, for AMA PRA Category 1 Credits™.
Participants may only claim a maximum of 2.50 AMA PRA Category 1 Credits™.
Available Credit
- 2.50 AMA PRA Category 1 Credit™
- 2.50 Certificate of Completion
Course Fee and Registration
The following is the course fee for each category. You will be asked to register for the course and provide payment information to complete the registration process.
• Clinical Congress attendees/Medical students - complimentary
• Resident members - $25
• Fellows and Affiliate MD/DO - $60
• Non-members - $80
Once you have completed the registration process, a confirmation email will be sent to you with the course information.
To Start Course
Once you have completed the registration process, you will see the "Take Course" button above. Click on the button to access the educational activity.
Prior to the live webinar on February 20, 2025, 6:00 - 7:00 pm CT, review the recorded content from the original session in San Francisco on the course page.
After the live webinar, return to the course page to access the enduring webinar recording, complete the course evaluation, and claim your certificate (if applicable).